Mesoblast Limited (MESO) Financials
MESO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | ? | ? |
2023-06-30 | 669.4 million | 167.6 million |
2023-03-31 | 650.4 million | 168.3 million |
2022-12-31 | 668.1 million | 168.1 million |
MESO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -14.4 million | ? |
2023-06-30 | -16.3 million | 1.1 million |
2023-03-31 | -16.3 million | 791000 |
2022-12-31 | -16.5 million | 1.4 million |
MESO Net Income
No data available :(
MESO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | - | - | - |
2023-06-30 | 70.9 million | - | 7.7 million |
2023-03-31 | 48.6 million | - | 8.3 million |
2022-12-31 | 67.2 million | - | 8.9 million |
MESO Shares Outstanding
MESO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 185000 | - | - | - |
2023-06-30 | 37000 | 6.7 million | 5.7 million | 8.7 million |
2023-03-31 | 40000 | 7.1 million | 6.4 million | 6.2 million |
2022-12-31 | 34000 | 7.7 million | 6.4 million | 7.9 million |
MESO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | 2.1 million | 8.7 million |
2023-03-31 | 1.9 million | 6.2 million |
2022-12-31 | 2.0 million | 251000 |
MESO
Price: $7.50
52 week price:
Earnings Per Share: -0.87 USD
P/E Ratio: -2.20
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 45251
Ebitda: -19.5 millionMarket Capitalization: 493.8 million